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Data from 264 chiklren and infants who underwent 
aortic balloon valvuloplasty between 1962 and 
1986, reported to the Valvuloplasty and Angio- 
plasty of Congenital Anomalies Registry, were re- 
viewed. Valvuloplasty was successful in 192 of 204 
children, reducing the peak systolii left ventricular 
ejectiongradientfrom77f2to26flmmHg,p 
<O.OOl. The same degree of aortic stenosis gradi- 
ents reduction was noted in both the 28 chiklren 
under 1 year of age and in the 166 children over 1 
year of age. Significant complications included 
death, aortic regurgitation and femoral artery 
thrombosis or damage. The incidence of these com- 
plications correlated with the age of the chikl, the 
ratio of valvuioplasty balloon size/anulus size, or 
both. The data suggest that percutaneous balloon 
valvuloplasty provides effective acute relief of val- 
var aortic stenosis in both infants and children. 
However, long-term follow-up data are necessary 
before balloon valvuloplasty can be established as a 
treatment of choice for congenital valvar aortic 
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D uring the past 5 years percutaneous balloon valvuloplasty has become the treatment of choice for valvar pulmonary stenosis. l -6 Balloon angio- 
plasty, however, still remains an experimental procedure 
for unoperated left-sided obstructive lesions.‘q8 Lababidi 
et a18,9 recently reported that percutaneous balloon dila- 
tion could be used to successfully treat valvar aortic ste- 
nosis. Others have also reported that valvuloplasty can 
successfully treat valvar aortic stenosis in both chil- 
drenr0-15 and adults.r6-l9 However, the total reported 
experience with balloon angioplasty to treat valvar aor- 
tic stenosis in the pediatric population is thus far only 
58 patients. In an attempt to evaluate the efficacy and 
safety of balloon valvuloplasty to treat children with 
valvar aortic stenosis in a large population, the results of 
Valvuloplasty and Angioplasty of Congenital Anomalies 
(VACA) Registry were reviewed. 
METHODS 
Patient population: Balloon aortic valvuloplasty was 
performed in 204 children (10.1 f 0.84 years of age) 
and the results were reported to the VACA Registry 
from January 1982 through December 1986. The age 
distribution of the patients is shown in Figure 1. All 
members of the VACA Registry were asked to com- 
plete a questionnaire on all patients in whom they per- 
formed balloon aortic valvuloplasty. The questionnaire 
contained the following information: date of birth, date 
of procedure, left ventricular and aortic pressures and 
cardiac output indexes before and immediately after 
valvuloplasty, aortic anulus dimension, valvuloplasty 
balloon dimension, inflation pressure and any complica- 
tions associated with the procedure. The data from the 
VACA Registry were then analyzed and form the basis 
of this report. 
No attempt was made by the registry to standardize 
valvuloplasty indications, the methods used to perform 
valvuloplasty or to obtain any follow-up information af- 
ter valvuloplasty. A single valvuloplasty balloon (rang- 
ing in diameter from 4 to 25 mm) was used in 163 sub- 
jects and 2 balloons side by side (ranging in diameter 
from 5 to 18 mm) were used in 23 subjects. Neither the 
balloon size nor number used were specified in 18 sub- 
jects. 
Statistical analysts: The data are presented as mean 
f standard deviation. Comparisons were made using ei- 
ther a 2-tailed t test for paired observations, analysis of 
variance or chi-square testing. Linear regression analy- 
sis was used to determine if a relation existed between 
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the ratio of balloon size/anulus size or patient age and 
the decrease in left ventricular pressure or outflow tract 
gradient. A p value <0.05 was required as evidence of 
significance. 
RESULTS 
Hemodynamic data: Table I lists hemodynamic data 
before and immediately after valvuloplasty from all 204 
subjects who had aortic balloon valvuloplasty attempt- 
ed. The peak systolic ejection gradient significantly de- 
creased from 77 f 28 to 30 f 14 mm Hg (p <O.OOl) 
(Figure 2). The decrease in peak systolic ejection gradi- 
ent was due to the combination of a significant decrease 
in left ventricular systolic pressure (p <O.OOl) and 
a significant increase in aortic systolic pressure (p 
<O.OOl) (Table I). No significant changes in cardiac 
index, aortic diastolic pressure or left ventricular end- 
diastolic pressure were observed after valvuloplasty. No 
relation was observed between the change in left ven- 
tricular systolic pressure or the change in left ventricu- 
lar outflow tract gradient and age for the group consid- 
ered as a whole (age vs change in gradient r = 1.23; age 
vs change in left ventricular pressure r = -0.08), or for 
infants (<l year of age) versus older children (Figure 
3). However, the results were poorer in those neonates 
in whom angioplasty was performed in the first week of 
life compared to the group as a whole (p <O.OOl) or 
compared to infants between the ages of 8 days and 1 
year (p <O.OOl). In addition, neither the valvuloplasty 
balloon size, the ratio of balloon/anulus diameters nor 
the use of 1 or 2 valvuloplasty balloons correlated with 
the degree of reduction in left ventricular systolic pres- 
sure or outflow tract gradient. 
Operative aortic valvotomy was subsequently re- 
quired in 4% (8 of 204) of the children. Balloon valvulo- 
plasty could not be performed in 4 of these patients be- 
cause it was not possible to cross the aortic valve in a 
retrograde fashion. Serious complications occurred be- 
fore performing the valvuloplasty in 2 children (left ven- 
tricular perforation and valvuloplasty catheter malfunc- 
FIGURE 1. The age disfribution of fhe 
204&ildrenwhowdemenfbaWoon 
aarfic valvulopbfy. 
TABLE I Hemodynamic Data Before and After Valvuloplasty 
in 186 Children for Whom Complete Data Were Reported to 
the Registry 
Before After 
No. Valvuloplasty Valvuloplasty p Value 
LV systokc 186 174f40 133 f 27 <0.001 
pressure 
(mm W 
LVED pressure 157 13f5 12f6 0.19 
(mm Hg) 
A0 systokc 186 96f 13 104f 13 <O.cQl 
pressure 
(mm Hg) 
A0 drastolic 186 63% 13 65i 13 0.11 
pressure 
(mm W 
Cardrac Index 103 4.1 f 1 3.9 f 1 0.06 
(Irters/min/m*) 
A0 = aort~c, ED = end-dlastollc. LV = left ventrmhr 
tion, nos. 9 and 10, Table II). The valvuloplasty was 
performed but did not effectively reduce the left ventric- 
ular outflow tract gradient to a nonsurgical level in the 
remaining 2 subjects. The left ventricular outflow gradi- 
ent only decreased from 80 to 60 mm Hg in 1 child and 
in the other, an infant, acidosis and seizures persisted 
despite a modest reduction in gradient (70 to 40 mm 
Hg) (no. 5, Table II). 
Complications: Major life-threatening complications 
occurred in 11 of 204 subjects (5%) (Table II). Five of 
the 11 children, all <l year of age, died either during 
the procedure (4 of 5) or within 2 days of the valvulo- 
plasty procedure (1 of 5). There were several specific 
causes of death in each of these 5. A 7-mm balloon 
catheter could not be advanced from the right femoral 
artery into the abdominal aorta in the first infant. On 
withdrawal of the catheter the iliac/femoral artery was 
torn and the child exanguinated. Valvuloplasty was not 
performed. A second infant had undergone a surgical 
valvotomy at 6 days of age. Due to persistent congestive 
Unknown 
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failure, aortic valvuloplasty was attempted. After 
the valvuloplasty the infant developed hypotension and 
bradycardia, and an aortogram demonstrated severe 
aortic regurgitation. The patient died approximately 1 
hour after the valvuloplasty. Necropsy examination re- 
vealed complete avulsion of the posterior aortic cusp. A 
third infant experienced a cardiac arrest and died due to 
aortic valve perforation and severe aortic insufficiency. 
A fourth infant had a combination of severe valvar aor- 
tic stenosis and a mild supravalvar stenosis. The infant 
died from tamponade shortly after the procedure. The 
ascending aorta was found to be very hypoplastic and a 
tear in the aortic root at the supravalvar ridge was not- 
ed at autopsy. The fifth infant (previously mentioned) 
died 2 days after an unsuccessful balloon valvuloplasty 
and subsequent surgical valvotomy. At necropsy, the in- 
fant was noted to have a transverse, circumferential tear 
in the aorta at the origin of the left common carotid 
artery. 
Other major complications included life-threatening 
arrhythmias in 3 patients, and in 1 child each perfora- 
tion of the left ventricle, requiring emergency pericar- 
diocentesis and surgery; dislodgement of the balloon 
portion of the valvuloplasty catheter in the ascending 
aorta over a guidewire in the left ventricle requiring 
emergency surgery to remove the balloon; and perfora- 
tion of the mitral valve (while performing balloon aortic 
valvuloplasty using an anterograde approach across the 
atria1 septum) requiring surgical repair of the mitral 
valve. Major complications were significantly related to 
age at valvuloplasty. Nine of 38 children <l year of age 
developed a major complication whereas only 2 of 166 
over 1 year of age had complications, yielding a relative 
risk of 25.5 for major complications in infancy (chi- 
square = 28.2; p <O.OOl). Angioplasty performed dur- 
ing the first month of life is associated with the highest 
rate of complications (Figure 4). 
Aortic regurgitation developed or increased in sever- 
ity in 21 of 204 children. The aortic regurgitation in- 
creased by I1 degree in 14 of the children, while the 
increase in regurgitation was moderate in 3 children 
and severe in 4. No difference in the incidence of aortic 
insufficiency existed between those patients under the 
age of 1 year (6 of 38) and those over the age of 1 year 
at the time of valvuloplasty (15 of 160). A significant 
relation was noted between the development of and se- 
verity of aortic insufficiency and the ratio of valvulo- 
plasty balloon size/aortic anulus size (Figure 5). 
Finally, significant bleeding requiring transfusion oc- 
curred in 5 of 204, while arterial thrombosis or damage 
was associated with the valvuloplasty procedure in 25 of 
204 (12%). Permanent loss of the femoral artery pulse 
occurred in 5 of 25 (20%) children. Three resulted from 
femoral arteries that could not be repaired. No explana- 
tion for the failure of femoral pulse to return to normal 
was given in 2 others. In the other 20 of 25 children the 
femoral pulse returned to normal after treatment with 
heparin in 4, streptokinase or urokinase in 7, or after 
surgical thrombectomy in 6. A significant association 
between age and femoral thrombosis was observed. Loss 
of femoral pulse occurred in 12 of 38 children under the 
age of 1 while only 13 of 160 children over the age of 1 
lost the femoral pulse (relative risk = 5.2, chi-square = 
86, p = 0.005). In an attempt to evaluate the relation 
between valvuloplasty balloon size (independent of age) 
and the incidence of femoral artery thrombosis, we 
compared the ratio of balloon size/anulus between 
those children who did and did not develop arterial 
thrombosis. The ratio of balloon size/anulus size was 
significantly larger in those children who developed ar- 
terial thrombosis (0.99 f 0.7 vs 0.91 f 0.03, p = 
0.023). 
DISCUSSION 
Hemodynamic results~ The management of infants 
and children with moderate to severe aortic stenosis can 
be challenging. When indicated, surgical aortic valvot- 
omy is an effective means of reducing the aortic stenosis 
gradient with a low mortality of 1 to 2% in children over 
the age of 1 year. 2om24 Surgical valvotomy must be con- 
sidered palliative therapy, however, since aortic regurgi- 
tation may occur and restenosis is common.25-29 The 
present study suggests that percutaneous balloon valvu- 
loplasty may provide an effective alternative to surgical 
palliation of valvar aortic stenosis in infants and chil- 
dren (> 1 week of age). Balloon valvuloplasty of the aor- 
tic valve decreased the peak systolic ejection gradient 
across the aortic valve in 192 of 204 infants and chil- 
dren to levels comparable to those achieved by surgical 
valvotomy. For children >l year of age aortic stenosis 
gradients after valvuloplasty averaged 30 f 6 mm Hg 
and for children <l year of age the gradients averaged 
27 f 51 mm Hg (Figure 3). Jones et a12r recently re- 
ported the results of surgical aortic valvotomy in 41 
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FIGURE 2. The cbtribution of change in aortk stenosis 
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children with valvar aortic stenosis over 1 year of age. 
Cardiac catheterization performed 1 year postoperative- 
ly showed a mean residual aortic gradient of 28 mm 
Hg. These other reports indicate that surgical valvot- 
omy can be expected to reduce the left ventricular out- 
flow tract gradient to approximately 25 to 40 mm Hg, 
results comparable to those observed in this study.21m29 
The mechanism by which balloon valvuloplasty re- 
duces the gradient in congenital valvar aortic stenosis 
has not been clearly defined, but evidence suggests that 
tears are produced along lines of commissural fusion. 
McKay et a130 performed necropsy or intraoperative 
balloon dilation in 3 patients with aortic stenosis and 
commissural fusion (1 with congenital bicuspid and 2 
with postrheumatic aortic stenosis). In each instance, 
balloon dilation resulted in separation of the fused com- 
missures along the commissural lines. Lababidi et ala9 
reported intraoperative observations of the aortic valve 
in 2 children who underwent elective surgical valvotomy 
after unsuccessful percutaneous balloon valvuloplasty. 
Each bicuspid aortic valve was found to have a 2- to 4- 
mm tear along the free edge of the fused commissure. 
The anatomic changes after more successful balloon 
aortic valvuloplasty in childhood have not been report- 
ed. 
Complications: In addition to documenting the acute 
efficacy of balloon aortic valvuloplasty for the treatment 
of valvar aortic stenosis, this study also documents a 
number of complications directly associated with the 
procedure, including death, aortic regurgitation, femo- 
ral artery thrombosis or damage, excessive blood loss, 
life-threatening arrhythmias and damage to other cardi- 
ac structures. Four deaths were directly related to the 
valvuloplasty procedure, and all 4 occurred in infants 
under the age of 3 months. However, critical aortic ste- 
nosis carries a grave prognosis even if treated surgical- 
1y.31-36 In a recent report by Pelech et al, 31 survival 
for neonates undergoing surgical therapy for critical 
aortic stenosis was only 43%. Even though the registry 
data do not specify why the 38 infants underwent bal- 
loon aortic valvuloplasty as opposed to surgical therapy, 
the survival rate of 87% for the valvuloplasty group is 
remarkable. When the causes of death in these infants 
were reviewed, we found that 1 of these deaths (no. 1, 
TABLE II Major Life-Threatening Complications Associated 
with Aortic Balloon Valvuloplasty 
Pt No. Age 
Balloon Anulus 
(mm) (mm) Complication 
1 51 mo 









5 dl mo 5 6 
6 51 mo 
7 51 mo 
8 51 mo 











Death due to esangurna- 
tion from a torn Iliac/ 
femoral artery 
Death due to avulsion of 
posterior cusp of aortrc 
valve 
Death due to aortrc valve 
perforatron 
Death due to rupture of 
ascending aorta at the 
site of a supravalvar 
ridge 
Death due to unsuccess- 
ful valvuloplasty and 
surgery; tear rn aorta 
at autopsy 
Bradycardia requiring re- 
suscitation 
Bradycardra requiring dis- 
continuing procedure 
Ventricular fib. during 
catheter exchange 
LV perforatron requiring 
emergency open heart 
surgery 
Catheter malfunctron re- 
qwing open heart sur- 
gery 
Mitral valve tear requiring 
open heart surgery 
Fib. = flbrlllatm; LV = left ventradar. 1 
Table II) may have been prevented if balloons on small- 
er catheter shafts had been available. 
Aortic regurgitation occurred in 10% of the children, 
a figure less than that reported by others.8~‘0*‘1 Mild to 
moderate aortic regurgitation has been reported in 10 to 
28% of patients after surgical valvotomy.26,27 Although 
the mechanism by which balloon valvuloplasty produces 
aortic regurgitation has not been clearly defined, perfo- 
ration of an aortic valve leaflet and avulsion of cusp 
tissue from the anulus were observed in 2 of the infants 
who died (nos. 2 and 3, Table II). We observed a rela- 
tion between the ratio of balloon/anulus size and both 
L 
FtGtJRE 3. The change in left ventricular (LV) systolic pressure, LV eutfbw tract (01) gradient and cardiac index in those 
children less than and greater than 1 year of age at the tims of aortic valdoptasty. AU values are mean f standard 
error of the mean. * p <O.OOl, before and after valvuloplesty. 
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q No Complication 
3-4 59 lo-14 1520 >20 
Years 
Unknown 
FtGURE 4. The dih+bdm of beben aortic valvukplasty cemplkation rate by age. The hii kddence of complkatiem 
ocamedindWren<l mnthofage. 
the presence and severity of aortic regurgitation; the in- 
cidence of aortic regurgitation might be reduced by us- 
ing smaller balloons. 
Femoral artery thrombosis, damage or both oc- 
curred in 12% of the children, and was most common in 
children under 1 year of age. Femoral artery patency 
was restored either with medical (heparin, streptokinase 
or urokinase) or surgical therapy in the majority of in- 
stances (80% of the time). Since the development of 
femoral artery damage was significantly related to both 
patient age and balloon/anulus ratio, the incidence of 
this complication may be significantly reduced by the 
development of new catheters with a smaller shaft size 
and a lower balloon profile. 
Study limitations: Two major limitations exist. First, 
since the VACA Registry only collected data on the 
acute response to aortic balloon valvuloplasty, we have 
no information to document the long-term efficacy of 
this procedure. However, based on the reported experi- 
ence of others,8-11J4 all of whose patients are included 
in this report, one can postulate that gradient reduction 
is likely for at least 1 year. To document the true long- 
term efficacy of aortic balloon valvuloplasty a multicen- 
ter long-term follow-up study, including repeat cathe- 
terization, will be necessary. 
N=175 N=lO N=7 
PcO.01 
-7% 
KtE MILD MOD-SEVERE 
POST VALVULOPLASTY INCREASE IN AR 
FIGURE 5. The reldon between the ratio of vaiwdqdaety 
baUoonsizetoaortlcamhssizeanddewbpmentofaortic 
regurghth (AR) aRer bdben wdvubphety. AH v&es 
are mean f  stadard en-or of lhe mean. MOD-SEVERE = 
modsrateto severe. 
The second limitation is that no attempt was made 
by the registry to standardize the methods used to per- 
form the valvuloplasty; thus, only limited conclusions 
can be made concerning the technical aspects of the val- 
vuloplasty procedure. In children in whom a single val- 
vuloplasty balloon was used (balloon/anulus ratio of 
0.56 to 1.5), no relation was noted between balloon/ 
anulus ratio and aortic stenosis gradient reduction. 
Since the complications of aortic regurgitation and fem- 
oral artery injury appear to relate to balloon/anulus ra- 
tio and since Helgason et al” have shown that a bal- 
loon/anulus ratio of >1.2 produced damage to aortic 
valve leaflets, mitral valve leaflets and intraventricular 
septum in normal lambs, a balloon/anulus ratio of II 
should be used. 
Clinical implications: These data suggest that percu- 
taneous balloon valvuloplasty provides effective acute 
relief of valvar aortic stenosis in both infants (>l week 
of age) and children. Significant complications of the 
valvuloplasty procedure included death, aortic regurgi- 
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tation and femoral artery thrombosis or damage. These 
complications, however, appeared to be uncommon if 
valvuloplasty was performed on children older than 1 
month of age, and if the balloon/anulus size ratio was 
5 1 .O. Long-term follow-up data should be collected be- 
fore percutaneous balloon valvuloplasty can be estab- 
lished as treatment of choice for children with valvar 
aortic stenosis. 
Acknowledgment: We would like to thank Gerald 
Serwer, MD, for assistance in the analysis of the data. 
REFERENCES 
1. Kveselis DA, Rocchini AP. Percutaneous transluminal angioplasty of peripher- 
al pulmonary artery stenosis, coarctation of the aorta, superior vena caval and 
pulmonary venous stenosis and other great artery stenoses. &win Intervent Ra- 
dial 1984;1:201-215. 
2. Lock JE, Keane JF, Fellows KE. The use of catheter interventional procedures 
for congenital heart disease. JACC 1967;7:1420-1423. 
3. Rocchini AP, Kveselis DA, Crowley D, Dick M, Rosenthal A. Percutaneous 
balloon valvuloplasty for treatment of congenital pulmonary valvular stenosis in 
children. Am J Cardiol 1984;3:1005-1012. 
4. Kan JS, White RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvulo- 
plasty: a new method for treating congenital pulmonary-valve stenosis. N End J 
Med 1982:307:540-542. 
5. Kan JS, White RI, Mitchell SE, Anderson JH, Gardner TJ. Percutaneous 
transluminal balloon valvuloplasty for pulmonic valve stenosis. Circularion 
1984:69:554-560. 
6. Kveselis DA, Rocchini AP, Snider AR, Rosenthal A, Crowley DC, Dick M. 
Results of balloon valvuloplasty in the treatment of congenital valvar pulmonary 
stenosis in children. Am J Cardiol 1985;56:527-532. 
7. Lock JE, Bass JL, Amplatz K, Fuhrman BP, Castaneda-Zuniga WR. Balloon 
dilatation angioplasty of coarctations in infants and children. Circulation 
1983;68:109-116. 
8. Lababidi Z, Wu JR, Walls TJ. Percutaneous balloon aortic valvuloplasty: 
results in 23 patients. Am J Cardiol 1984:53:194-197. 
9. Walls JT, Lababidi Z, Curtes JJ, Silver D. Assessment of percutaneous balloon 
pulmonary and aortic valvuloplasty. J Thorac Cardimasc Surg 1984;88:352-356. 
10. Choy M, Beckman RH, Rocchini AP, Crowley DC, Snider AR, Dick M, 
Rosenthal A. Percutaneous balloon valvuloplasty for aortic stenosis in infants and 
children. Am J Cardiol 1987:59:1010~1013. 
11. Helgason H. Keane JF, Fellows KE, Kulik TJ, Lock JE. Balloon dilation of 
the aortic valve. Studies in normal lambs and in children with aortic stenosis. 
JACC 1987;9:816-822. 
12. Sanchez CR, Mehta AV, Ewing LL, Brickley SE, Anderson TM, Black IFA. 
Successful percutaneous balloon valvuloplasty of the aortic valve in an infant. 
Pediatr Cwdiol 1985,6:103-106. 
13. Rupprath G, Neuhaus KL. Percutaneous balloon aortic valvuloplasty in 
infancy and childhood. Am J Cardiol /985;55:/855-1856. 
14. Wailer BF, Girod DA, Dillion JC. Transverse aortic wall tears in infants after 
balloon angioplasty for aortic valve stenosis: relation of aortic wall damage to 
diameter of inflated angioplasty balloon and aortic lumen in seven necropsy cases. 
JACC 1984;4:1235-1241. 
15. Richards AF. Somerville J. Successful balloon aortic valvotomy in a child 
with a pulmonary hypertensive duct and aortic valve stenosis. BI Heart J 
1986;56:185-186. 
16. McKay RG. Salian RD. Lock JE, Diver DJ, Berman AD, Warren SE. Come 
PC, Bairn DS. Mandell VE. Royal HD. Grossman W. Assessment ofleft ventricu- 
lar and aortic valve function after aortic balloon valvuloplasty in adult patients 
with critical aortic stenosis. Circulation /987:75:/92-203. 
17. Crib& A, Souudi N, Berland J, Savin T ,  Rocha P. Letac B. Percutaneous 
transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alter- 
native to valve replacement? Lancer /986:/:63-67. 
18. lsner JM. Salem DN, Desnoyers MR, Hougen TH, Mackey WC, Pandian 
NC, Eickhorn EJ, Konstam MA, Levine HJ. Treatment ofcalcilic aortic stenosis 
by balloon valvuloplasty. Am J Cardiol /987:59:3/3-317. 
19. Sitian RD. Mandell VS, Thurer RE, Hutchins GM. Schnitt SJ. Grossmen W. 
McKay RG. Postmortem and intraoperative balloon valvuloplasty of calcific 
aortic stenosis in elderly patients: mechanism of successful dilation. JACC 
I987:9:655-660. 
20. Sandor GGS, Olley PM, Trusleer GA. Williams WG, Rowe RD. March JE. 
Long-term follow-up of patients after valvotomy for congenital valvular aortic 
stenosis in children. J Thorac Cardioazsc Surg 1980;80:171-176. 
21. Jones M, Barnhart GR, Morrow AG. Late results after operations for left 
ventricular outflow tract obstruction. Am J Cardiol /982;50.569-579. 
22. Fisher RD, Mason DT, Morrow AG. Results of operative treatment in 
congenital aortic stenosis. Pre- and postoperative hemodynamic evaluations. J 
Thorac Cardiouasc Surg 1970;59:2/8-224 
23. Hossack KF, Neutze LM, Lowe JB, Barratt-Boyes BG. Congenital valvar 
aortic stenosis: natural history and assessment for operation. Br Hearr J 
/980;43:561-573. 
24. Ankeney JL, Tzeng TS, Liebman J. Surgical therapy for congenital aortic 
valvular stenosis. J Thorac Cardiooasc Surg 1983:85:4/-48. 
25. Presbitero P, Somerville J, Revel-Chion R, Ross D. Congenital aortic stenosis, 
late results. Br Heart J 1982:47:26-34. 
26. Conkle DM, Jones M, Morrow AG. Treatment of congenital aortic stenosis. 
Arch Surg 1973;107:649-651. 
27. Jack WD. Kelly DT. Long-term follow-up of valvulotomy for congenital 
aortic stenosis. Am J Cardiol /976;38:23/-234. 
28. Wagner HR, Ellison RC, Keane JF, Humphries JO, Nadas AS. Clinical 
course in aortic stenosis. Circulation 1977;56(suppl 1)/47-157. 
29. Hsieh KS, Keane JF, Nadas AS, Bernhard WF, Castaneda AR. Long-term 
follow-up of valvotomy before I968 for congenital aortic stenosis. Am J Cardiol 
1986;58:338-341. 
30. McKay RG, Safian RD. Lock JE, Mandell VS. Thurer RL. Schnitt SJ. 
Grossman W. Balloon dilatation of calcitic aortic stenosis in elderly patients. 
Postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation 
/986;74:lI9%125. 
31. Pelech A, Dyck J, Freedom R, Olley P, Williams WG. Critical aortic stenosis 
in the neonate: survival and management (abstr). Circulation /984:7O(supp/ 
Ifl:11-132. 
32. Lees MH. Hauch AJ, Starkey GWB. Nadas AS, Gross RE. Congenital 
aortic stenosis: operative indications and surgical results. Br Heart J /96/:24:3/b 
39. 
33. Keane JF, Bernhard WF, Nadas AS. Aortic stenosis in infancy. Circtdation 
1975;52./138-1145. 
34. Trinkle JK, Bernhard WF. Nadas AS. Aortic valvotomy in infants. Late 
results. J Thorar Cardiooasc Surg 1978;76:198-206. 
35. Edmunds LH. Wagner HR, Heymann MA. Aorticvalvulotomy in neonates. 
Circulation 1980;61:421-432. 
36. Brown JW, Robinson RJ, Wailer BF. Transventricular balloon catheter 
aortic valvotomy in neonates. Ann Thor-m Surg /985:39.376-378. 
THE AMERICAN JOURNAL OF CARDIOLOGY MARCH 15. 1990 789 
